✦ LIBER ✦

Biological Perspectives : Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs): Venlafaxine and Duloxetine

✍ Scribed by Stacey I. Lee; Norman L. Keltner

Book ID: 111321375
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 77 KB
Volume: 42
Category: Article
ISSN: 0031-5990
DOI: 10.1111/j.1744-6163.2006.00064.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Duloxetine (Cymbalta), a Dual Inhibitor

Duloxetine (Cymbalta), a Dual Inhibitor of Serotonin and Norepinephrine Reuptake.

✍ F. P. Bymaster; E. E. Beedle; J. Findlay; P. T. Gallagher; J. H. Krushinski; S. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 113 KB 👁 1 views

Duloxetine (Cymbalta™), a dual inhibitor

Duloxetine (Cymbalta™), a dual inhibitor of serotonin and norepinephrine reuptake

✍ F.P. Bymaster; E.E. Beedle; J. Findlay; P.T. Gallagher; J.H. Krushinski; S. Mitc 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Serotonin norepinephrine reuptake inhibi

Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy

✍ Bernardo Dell'Osso; Massimiliano Buoli; David S. Baldwin; A. Carlo Altamura 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## Abstract Anxiety disorders are common psychiatric conditions that typically require long‐term treatment. This review summarizes current knowledge of the pharmacological treatment of anxiety disorders with serotonin norepinephrine reuptake inhibitors (SNRIs) with specific emphasis on the findings

Benzothienyloxy Phenylpropanamines, Nove

Benzothienyloxy Phenylpropanamines, Novel Dual Inhibitors of Serotonin and Norepinephrine Reuptake.

✍ P. T. Gallagher; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 16 KB 👁 1 views

Milnacipran: The Clinical Properties of

Milnacipran: The Clinical Properties of a Selective Serotonin and Noradrenaline Reuptake Inhibitor (SNRI)

✍ Y. Lecrubier 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Milnacipran is a novel antidepressant agent which selectively inhibits the reuptake of serotonin and noradrenaline without directly aecting postsynaptic receptor sites. The biochemical and pharmacological pro®le of milnacipran suggested that the drug would be therapeutically eective and well tolerat

Discovery and Structure—Activity Relatio

Discovery and Structure—Activity Relationships of Novel Selective Norepinephrine and Dual Serotonin/Norepinephrine Reuptake Inhibitors.

✍ Magnus W. Walter; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 26 KB 👁 1 views

## Abstract For Abstract see ChemInform Abstract in Full Text.